CORRECTED-INDIAN DRUG REGULATOR'S SEC COMMITTEE HAS GIVEN CONDITIONAL APPROVAL FOR MERCK'S COVID-19 PILL MOLNUPIRAVIR - CNBC-TV18 (CORRECTS TO CLARIFY DRUG REGULATOR'S PANEL)
Indian Drug Regulator's Sec Committee Has Given Conditional Approval For Merck's Covid-19 Pill Molnupiravir - Cnbc-Tv18 (Corrects To Clarify Drug Regulator's Panel)
![Reuters logo](/images/reuters.jpg)